InvestorsHub Logo
Followers 105
Posts 4947
Boards Moderated 0
Alias Born 10/20/2015

Re: extrooper post# 480422

Wednesday, 06/01/2022 9:25:00 AM

Wednesday, June 01, 2022 9:25:00 AM

Post# of 691823
That is exactly correct. The true value of these small Biotechs are disconnected from the market price due to the fact that short sellers do damage to the company by offers to sell short the naked float at times that the company is trying to raise capital by selling actual newly minted shares. This can depress the price to extreme levels and in many cases completely destroy the company. The trick is to value the company through
DD and to slowly accumulate over many years with expectations one should be prepared to hold for at least 5 years to realize that value. An important aspect of choosing a biotech is not only the Tech, Science, and IP but also the ability of the company to navigate and survive the regulatory desert, the long stretches of time that money is tight and price suppressed by phantom counterfeit shares being sold short to compete with actual shares being sold by the company to raise cash. I place a 5 year price target greater than $40 billion but the market cap could explode upwards on any day with out of the blue news like a partnership.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News